Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Ways To Get Paid Fast For Freelance Work
Freelancers often seek quick payment solutions. Explore effective ways to ensure you get paid fast for your hard work.
15,585 articles
Bitter Dispute Drags Between Pitt and Jolie Winery
A Paris court setback keeps the ownership fight over the Miraval winery alive as investors weigh the financial stake ...
Stock Market Today, July: Grab Falls as Uber CEO Exits
Grab's stock move mirrors a broader tech and regional risk beat. As Uber's board change unfolds, investors weigh grow...
Morgan Stanley: SpaceX Could Rally 87% as Wall Street Backs
A new market note lays out an upside case for SpaceX, predicting an 87% rally on the back of quick index inclusion an...
Microsoft Looks Make Major Reset: Gaming Pivot Strategy
Microsoft is not shrinking its ambitions. In this deep dive, we explore how the tech giant aims to reset its gaming d...
Apollo Sounds Alarm: AI Profits Falter Beyond Tech
A fresh Apollo analysis flags a widening profit gap for AI initiatives outside core tech, threatening AI-heavy ETFs a...
Microsoft’s Brad Smith Washington’s Push for Clear AI Rules Takes Center Stage
Microsoft’s Brad Smith Washington’s calls for clear, transparent AI rules intensify the policy debate in Washington, ...
Victoria Beckham Appears Extend Olive Branch at Miami Launch
A high-profile Miami pop-up marks more than a fashion moment. This article dives into how Victoria Beckham Appears Ex...
Trump Made Stock Trades: Tech Giants and Market Moves
A surprising disclosure spotlighted a flurry of activity around big tech stocks. This article breaks down what it cou...
Bloom Energy Next NVIDIA? Is This Stock Tale Real?
Could Bloom Energy ride AI demand like Nvidia did? This comprehensive guide weighs the parallels, the risks, and prac...
Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Why I Won’t Buy a Rivian: Investor Caution in 2026
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status